CONTINGENT NEGATIVE-VARIATION AND EVOKED-POTENTIAL AMPLITUDE AS A FUNCTION OF INSPIRED NITROUS-OXIDE CONCENTRATION

被引:23
作者
FENWICK, P
BUSHMAN, J
HOWARD, R
PERRY, I
GAMBLE, T
机构
[1] INST PSYCHIAT,LONDON SE5 8AF,ENGLAND
[2] ROYAL COLL SURG ENGLAND,DEPT ANAESTHET,LONDON WC2A 3PN,ENGLAND
[3] BROADMOOR HOSP,DEPT EEG,CROWTHORNE,BERKSHIRE,ENGLAND
[4] GUYS HOSP,SCH MED,LONDON SE1 9RT,ENGLAND
[5] SYNTHOLAB,F-75621 PARIS 13,FRANCE
来源
ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY | 1979年 / 47卷 / 04期
关键词
D O I
10.1016/0013-4694(79)90163-9
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Nine subjects were given to breath 10%, 20%, 30% and 40% nitrous oxide in oxygen. The inhaled gas concentrations were monitored by a mass spectrograph. At each gas concentration the CNV was measured in a standard long S1-S2 CNV paradigm to a click and tone with a mandatory button press at S2. The results confirmed the previous observations of Lader and Morris (1974) that the cortical evoked potential decreases rapidly with increasing concentrations of nitrous oxide. The CNV, however, against prediction remains surprisingly well preserved up to the borders of unconsciousness. In this situation there is little correlation between CNV amplitude and attention, arousal or reaction time. © 1979.
引用
收藏
页码:473 / 482
页数:10
相关论文
共 18 条
[1]  
Bernard C, 1875, LECONS ANESTHESIQUES
[2]  
CALLAWAY E, 1975, BRAIN ELECTRICAL POT
[3]  
DAVIS H, 1977, 9TH INT C EL CLIN NE
[4]  
DAVY H, 1800, RES CHEM PHILOSOPHIC
[5]   The use of chemical potentials as indices of toxicity [J].
Ferguson, J .
PROCEEDINGS OF THE ROYAL SOCIETY SERIES B-BIOLOGICAL SCIENCES, 1939, 127 (848) :387-404
[6]   EFFECTS OF NITROUS OXIDE ON HUMAN AUDITORY EVOKED RESPONSE [J].
LADER, M ;
NORRIS, H .
PSYCHOPHARMACOLOGIA, 1969, 16 (02) :115-&
[7]  
LADER MH, 1971, PSYCHOPHARMACOLOGIA, V20, P201
[8]  
Lee John A., 1968, SYNOPSIS ANAESTHESIA, V6th
[9]   EFFECTS OF ATTENTION AND DISTRACTION ON CONTINGENT NEGATIVE VARIATION IN NORMAL AND NEUROTIC SUBJECTS [J].
MCCALLUM, WC ;
WALTER, WG .
ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1968, 25 (04) :319-&
[10]  
Meyer H, 1899, ARCH EXP PATH PHARMA, V42, P109